Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL914 (Allegra, Fexofenadina, Fexofenadine) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG channel | B | 4.64 | pKi | 23000 | nM | Ki | J Med Chem (2015) 58: 2584-2608 [PMID:25494650] |
ChEMBL | Inhibition of human ERG in L929 cells at 10 uM by whole cell patch-clamp assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5043-5047 [PMID:19660947] |
ChEMBL | Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method | B | 4.19 | pIC50 | 65000 | nM | IC50 | J Med Chem (2009) 52: 1630-1638 [PMID:19260734] |
ChEMBL | Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1 | B | 4.64 | pIC50 | 23000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1829-1835 [PMID:12729675] |
ChEMBL | Inhibition of human Erg expressed in HEK293 cells assessed as rubidium efflux after 4 hrs by atomic absorbance spectrometric analysis | B | 4.64 | pIC50 | 23000 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 3781-3785 [PMID:22542010] |
ChEMBL | Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assay | B | 4.64 | pIC50 | 23000 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 5507-5512 [PMID:16931010] |
ChEMBL | Inhibition of human ERG | B | 4.64 | pIC50 | 22908.68 | nM | IC50 | Eur J Med Chem (2011) 46: 618-630 [PMID:21185626] |
ChEMBL | K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1 | F | 4.67 | pIC50 | 21570 | nM | IC50 | J Med Chem (2002) 45: 3844-3853 [PMID:12190308] |
ChEMBL | Inhibition of human ERG in MCF7 cells | B | 4.67 | pIC50 | 21379.62 | nM | IC50 | Eur J Med Chem (2009) 44: 1926-1932 [PMID:19110341] |
ChEMBL | Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state | F | 4.67 | pIC50 | 21379.62 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 1737-1741 [PMID:15745831] |
ChEMBL | Inhibition of human ERG in L929 cells by whole cell patch-clamp assay | B | 7 | pIC50 | >100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5043-5047 [PMID:19660947] |
H1 receptor/Histamine H1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL231] [GtoPdb: 262] [UniProtKB: P35367] | ||||||||
ChEMBL | Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting | B | 7.57 | pKi | 27 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 5043-5047 [PMID:19660947] |
GtoPdb | - | - | 7.57 | pKi | 27 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 5043-7 [PMID:19660947] |
ChEMBL | Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting | B | 7.11 | pIC50 | 78 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 2766-2771 [PMID:19362477] |
ChEMBL | Inhibition of histamine H1 receptor | B | 7.11 | pIC50 | 78 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 2766-2771 [PMID:19362477] |
ChEMBL | Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting | B | 7.11 | pIC50 | 78 | nM | IC50 | Bioorg Med Chem (2011) 19: 3005-3021 [PMID:21470866] |
ChEMBL | Inhibition of histamine H1 receptor (unknown origin) | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2015) 58: 2584-2608 [PMID:25494650] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]